MTCO2P12 and type 2 diabetes mellitus: Anti-inflammatory drugs, including nonselective (aspirin) and selective COX-2 inhibitors, have been studied to reduce cardiovascular risk and recurrence of cardiovascular events in patients with T2D (Huang and Vita, 2006).